Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
58.2M
-
Shares change
-
+9.4M
-
Total reported value, excl. options
-
$646M
-
Value change
-
+$108M
-
Put/Call ratio
-
0.22
-
Number of buys
-
77
-
Number of sells
-
-44
-
Price
-
$11.10
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2019
167 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2019.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.2M shares
of 157M outstanding shares and own 37% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.88M shares), BlackRock Inc. (6.03M shares), GREAT POINT PARTNERS LLC (5.43M shares), VANGUARD GROUP INC (4.24M shares), STATE STREET CORP (3.41M shares), MILLENNIUM MANAGEMENT LLC (3.1M shares), BRIDGER MANAGEMENT, LLC (1.91M shares), FMR LLC (1.75M shares), GOLDMAN SACHS GROUP INC (1.22M shares), and RENAISSANCE TECHNOLOGIES LLC (1.18M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.